GHK-Cu

Research Papers and Clinical Trials

The available research on GHK-Cu (glycyl-L-histidyl-L-lysine-copper) spans multiple therapeutic areas, though most studies are preliminary or conducted in animal/laboratory models.

Wound Healing and Skin Applications
Several recent studies have explored GHK-Cu's potential in wound healing. A 2026 study published in Materials today. Bio investigated copper peptide cascade catalysis for glucose regulation and hypoxia reversal in infected diabetic wounds, though specific study details and sample sizes were not provided in the available evidence. Another 2026 study in Bioactive materials examined injectable hydrogels containing GHK-Cu for treating radiation-induced skin injury, focusing on antioxidant and tissue regeneration properties.

Aging and Neurological Effects
Research has examined GHK-Cu's potential anti-aging effects across different model systems. A 2026 study in Biogerontology investigated GHK-Cu's effects on aging in Caenorhabditis elegans (a laboratory worm model), finding that the peptide may delay aging through mitochondrial function regulation and activation of specific cellular pathways (DAF-16/SKN-1).

In mammalian research, a 2026 study published in Research square examined middle-aged mice treated with GHK-Cu through different administration routes (intraperitoneal or intranasal). The study reported "behavioral rescue" but noted divergent effects on hippocampal aging programs depending on delivery method, though specific sample sizes and detailed outcomes were not provided in the available abstracts.

Clinical Trial Evidence
Currently active clinical research includes a Phase 2 trial (NCT07437586) investigating topical GHK-Cu gel for acute skin wound healing, which is currently recruiting participants. A completed Phase 4 trial (NCT05932732) assessed facial skin treatments, though this study's specific focus on GHK-Cu versus other treatment components is unclear from the available information.

Research Limitations
The evidence base remains limited, with most studies conducted in laboratory models or animal systems. Sample sizes, detailed methodologies, and comprehensive outcome data are not available in the provided abstracts, making it difficult to assess the clinical significance of findings. Human clinical trial data specifically for GHK-Cu applications appears limited.

This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals for personalized treatment recommendations.